These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


99 related items for PubMed ID: 26103129

  • 1. n-3 fatty acids reduce plasma 20-hydroxyeicosatetraenoic acid and blood pressure in patients with chronic kidney disease.
    Barden AE, Burke V, Mas E, Beilin LJ, Puddey IB, Watts GF, Irish AB, Mori TA.
    J Hypertens; 2015 Sep; 33(9):1947-53. PubMed ID: 26103129
    [Abstract] [Full Text] [Related]

  • 2. The effect of n-3 fatty acids and coenzyme Q10 supplementation on neutrophil leukotrienes, mediators of inflammation resolution and myeloperoxidase in chronic kidney disease.
    Barden AE, Shinde S, Burke V, Puddey IB, Beilin LJ, Irish AB, Watts GF, Mori TA.
    Prostaglandins Other Lipid Mediat; 2018 May; 136():1-8. PubMed ID: 29577973
    [Abstract] [Full Text] [Related]

  • 3. n-3 Fatty Acid Supplementation and Leukocyte Telomere Length in Patients with Chronic Kidney Disease.
    Barden A, O'Callaghan N, Burke V, Mas E, Beilin LJ, Fenech M, Irish AB, Watts GF, Puddey IB, Huang RC, Mori TA.
    Nutrients; 2016 Mar 19; 8(3):175. PubMed ID: 27007392
    [Abstract] [Full Text] [Related]

  • 4. A randomized controlled trial of the effects of n-3 fatty acids on resolvins in chronic kidney disease.
    Mas E, Barden A, Burke V, Beilin LJ, Watts GF, Huang RC, Puddey IB, Irish AB, Mori TA.
    Clin Nutr; 2016 Apr 19; 35(2):331-336. PubMed ID: 25908532
    [Abstract] [Full Text] [Related]

  • 5. 20-HETE and F2-isoprostanes in the metabolic syndrome: the effect of weight reduction.
    Tsai IJ, Croft KD, Mori TA, Falck JR, Beilin LJ, Puddey IB, Barden AE.
    Free Radic Biol Med; 2009 Jan 15; 46(2):263-70. PubMed ID: 19013235
    [Abstract] [Full Text] [Related]

  • 6. A reduction in alcohol consumption is associated with reduced plasma F2-isoprostanes and urinary 20-HETE excretion in men.
    Barden A, Zilkens RR, Croft K, Mori T, Burke V, Beilin LJ, Puddey IB.
    Free Radic Biol Med; 2007 Jun 01; 42(11):1730-5. PubMed ID: 17462541
    [Abstract] [Full Text] [Related]

  • 7. Prenatal omega-3 fatty acid supplementation does not affect offspring telomere length and F2-isoprostanes at 12 years: A double blind, randomized controlled trial.
    See VH, Mas E, Burrows S, O'Callaghan NJ, Fenech M, Prescott SL, Beilin LJ, Huang RC, Mori TA.
    Prostaglandins Leukot Essent Fatty Acids; 2016 Sep 01; 112():50-5. PubMed ID: 27637341
    [Abstract] [Full Text] [Related]

  • 8. Effects of postnatal omega-3 fatty acid supplementation on offspring pro-resolving mediators of inflammation at 6 months and 5 years of age: A double blind, randomized controlled clinical trial.
    See VHL, Mas E, Prescott SL, Beilin LJ, Burrows S, Barden AE, Huang RC, Mori TA.
    Prostaglandins Leukot Essent Fatty Acids; 2017 Nov 01; 126():126-132. PubMed ID: 29031390
    [Abstract] [Full Text] [Related]

  • 9. The effects of [omega]3 fatty acids and coenzyme Q10 on blood pressure and heart rate in chronic kidney disease: a randomized controlled trial.
    Mori TA, Burke V, Puddey I, Irish A, Cowpland CA, Beilin L, Dogra G, Watts GF.
    J Hypertens; 2009 Sep 01; 27(9):1863-72. PubMed ID: 19705518
    [Abstract] [Full Text] [Related]

  • 10. The omega-3 fatty acids EPA and DHA decrease plasma F(2)-isoprostanes: Results from two placebo-controlled interventions.
    Mas E, Woodman RJ, Burke V, Puddey IB, Beilin LJ, Durand T, Mori TA.
    Free Radic Res; 2010 Sep 01; 44(9):983-90. PubMed ID: 20540666
    [Abstract] [Full Text] [Related]

  • 11. A Randomized Trial of Effects of Alcohol on Cytochrome P450 Eicosanoids, Mediators of Inflammation Resolution, and Blood Pressure in Men.
    Barden AE, Chavez V, Phillips M, Mas E, Beilin LJ, Croft KD, Mori TA, Puddey IB.
    Alcohol Clin Exp Res; 2017 Oct 01; 41(10):1666-1674. PubMed ID: 28767146
    [Abstract] [Full Text] [Related]

  • 12. Effect of Omega-3 Fatty Acid Supplementation on Plasma Fibroblast Growth Factor 23 Levels in Post-Myocardial Infarction Patients with Chronic Kidney Disease: The Alpha Omega Trial.
    de Borst MH, Baia LC, Hoogeveen EK, Giltay EJ, Navis G, Bakker SJL, Geleijnse JM, Kromhout D, Soedamah-Muthu SS.
    Nutrients; 2017 Nov 11; 9(11):. PubMed ID: 29137111
    [Abstract] [Full Text] [Related]

  • 13. The effect of a single nucleotide polymorphism of the CYP4F2 gene on blood pressure and 20-hydroxyeicosatetraenoic acid excretion after weight loss.
    Ward NC, Croft KD, Puddey IB, Phillips M, van Bockxmeer F, Beilin LJ, Barden AE.
    J Hypertens; 2014 Jul 11; 32(7):1495-502; discussion 1502. PubMed ID: 24984178
    [Abstract] [Full Text] [Related]

  • 14. Urinary 20-hydroxyeicosatetraenoic acid excretion is associated with oxidative stress in hypertensive subjects.
    Ward NC, Puddey IB, Hodgson JM, Beilin LJ, Croft KD.
    Free Radic Biol Med; 2005 Apr 15; 38(8):1032-6. PubMed ID: 15780761
    [Abstract] [Full Text] [Related]

  • 15. Coenzyme Q10 improves blood pressure and glycaemic control: a controlled trial in subjects with type 2 diabetes.
    Hodgson JM, Watts GF, Playford DA, Burke V, Croft KD.
    Eur J Clin Nutr; 2002 Nov 15; 56(11):1137-42. PubMed ID: 12428181
    [Abstract] [Full Text] [Related]

  • 16. Fish oil supplementation in pregnancy lowers F2-isoprostanes in neonates at high risk of atopy.
    Barden AE, Mori TA, Dunstan JA, Taylor AL, Thornton CA, Croft KD, Beilin LJ, Prescott SL.
    Free Radic Res; 2004 Mar 15; 38(3):233-9. PubMed ID: 15129731
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of 20-hydroxyeicosatetraenoic acid synthesis using specific plant lignans: in vitro and human studies.
    Wu JH, Hodgson JM, Clarke MW, Indrawan AP, Barden AE, Puddey IB, Croft KD.
    Hypertension; 2009 Nov 15; 54(5):1151-8. PubMed ID: 19786646
    [Abstract] [Full Text] [Related]

  • 18. The effect of n-3 polyunsaturated fatty acids on leukotriene B₄ and leukotriene B₅ production from stimulated neutrophil granulocytes in patients with chronic kidney disease.
    Maaløe T, Schmidt EB, Svensson M, Aardestrup IV, Christensen JH.
    Prostaglandins Leukot Essent Fatty Acids; 2011 Jul 15; 85(1):37-41. PubMed ID: 21530211
    [Abstract] [Full Text] [Related]

  • 19. Intakes of omega-3 polyunsaturated fatty acids and blood pressure change over time: Possible interaction with genes involved in 20-HETE and EETs metabolism.
    Tagetti A, Ericson U, Montagnana M, Danese E, Almgren P, Nilsson P, Engström G, Hedblad B, Minuz P, Orho-Melander M, Fava C, Melander O.
    Prostaglandins Other Lipid Mediat; 2015 Jul 15; 120():126-33. PubMed ID: 25986600
    [Abstract] [Full Text] [Related]

  • 20. The effects of a lupin-enriched diet on oxidative stress and factors influencing vascular function in overweight subjects.
    Yang X, Croft KD, Lee YP, Mori TA, Puddey IB, Sipsas S, Barden A, Swinny E, Hodgson JM.
    Antioxid Redox Signal; 2010 Nov 15; 13(10):1517-24. PubMed ID: 20214496
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.